12/17/2024
8:00 AM | Sonnet BioTherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/17/2024
7:50 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:25 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:20 AM | Sonnet BioTherapeutics (Filer)
| Form 424B5 | |
12/09/2024
7:50 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
8:55 PM | Cross John Harry III (Reporting)
Sonnet BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
8:55 PM | Kenney Richard T (Reporting)
Sonnet BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/05/2024
8:55 PM | Mohan Pankaj (Reporting)
Sonnet BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
8:55 PM | Griffith Donald J. (Reporting)
Sonnet BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
8:55 PM | Cini John K. (Reporting)
Sonnet BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
8:55 PM | Rao Raghu (Reporting)
Sonnet BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
8:55 PM | Dyrness Albert D. (Reporting)
Sonnet BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
8:55 PM | McNeill Lori (Reporting)
Sonnet BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
8:55 PM | Dexter Susan (Reporting)
Sonnet BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
8:55 PM | Bhatt Nailesh (Reporting)
Sonnet BioTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
8:20 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
4:15 PM | Sonnet BioTherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/08/2024
7:30 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
8:22 AM | Sonnet BioTherapeutics (Filer)
| Form 424B4 | |
11/06/2024
11:15 PM | Sonnet BioTherapeutics (Filer)
| Form EFFECT | |
11/06/2024
8:22 AM | Sonnet BioTherapeutics (Filer)
| Form S-1/A | |
11/06/2024
7:48 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
8:01 AM | Sonnet BioTherapeutics (Filer)
| Form S-1/A | |
10/28/2024
8:01 AM | Sonnet BioTherapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/17/2024
7:50 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
7:56 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
7:30 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
7:36 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
4:15 PM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
7:30 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
4:27 PM | Sonnet BioTherapeutics (Filer)
| Form DEF 14A | |
08/19/2024
4:28 PM | Sonnet BioTherapeutics (Filer)
| Form ARS | |
08/19/2024
7:50 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:41 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:45 AM | Sonnet BioTherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
4:28 PM | Sonnet BioTherapeutics (Filer)
| Form PRE 14A | |
07/24/2024
7:36 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
11:15 PM | Sonnet BioTherapeutics (Filer)
| Form EFFECT | |
07/15/2024
4:05 PM | Sonnet BioTherapeutics (Filer)
| Form 424B3 | |
07/05/2024
3:06 PM | Sonnet BioTherapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/20/2024
3:49 PM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
06/13/2024
7:15 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
6:35 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
8:25 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
11:15 PM | Sonnet BioTherapeutics (Filer)
| Form EFFECT | |
05/14/2024
4:25 PM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
7:30 AM | Sonnet BioTherapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
05/03/2024
7:00 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
6:30 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
3:20 PM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:35 AM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:30 AM | Sonnet BioTherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
01/04/2024
11:15 PM | Sonnet BioTherapeutics (Filer)
| Form EFFECT | |
12/27/2023
3:56 PM | Sonnet BioTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
3:31 PM | Sonnet BioTherapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
